Multicomponent Intervention Study- Blood Donors With High Cholesterol
Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia
University of Texas Southwestern Medical Center
100 participants
Feb 27, 2023
INTERVENTIONAL
Conditions
Summary
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
Eligibility
Inclusion Criteria2
- Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
- Age 18 to 75 years
Exclusion Criteria5
- Currently taking medication to lower cholesterol
- Taking any medication that can interact with statins
- Pregnancy
- Identified secondary cause of elevated lipids
- Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bundle includes multimodal communications to notify donors about high cholesterol and its treatment, website with resources, and an optional care navigator. Resources for their primary care provider will also be disseminated.
Carter BloodCare will notify participants of their high cholesterol, potential for genetic causes, and recommendation to see their care provider by sending its routine, standard notification letter. These participants will also be eligible to receive the intervention bundle at the end of the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05693701